Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2023 EPS estimates for Karuna Therapeutics in a report issued on Wednesday, November 8th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of ($11.02) per share for the year, down from their prior estimate of […]
Karuna Therapeutics (NASDAQ:KRTX – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada from $235.00 to $225.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 21.35% […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,670,000 shares, a growth of 18.4% from the September 15th total of 1,410,000 shares. Based on an average daily volume of 252,200 shares, […]
Moody Aldrich Partners LLC decreased its holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 27.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,427 shares of the company’s stock after selling 3,480 shares during the quarter. Moody Aldrich Partners LLC’s […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price objective […]